CHRNA7 and non-small cell lung carcinoma: An increase in the neurotransmitter, noradrenaline, accompanied nicotine treatment of NSCLC cells and resulted in increased cell proliferation, effects that were reversed by the α7nAChR antagonist α-BTX or the β-blocker propranolol [8].